secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0001493152-24-048431
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics appeals Nasdaq delisting; hearing set for Jan 30, 2025
------------------------------------------------------------------------------

- Nasdaq determined non-compliance with $2.5M stockholders' equity requirement (Rule 5550(b)(1)).
- Company failed to regain compliance by Nov 18, 2024 extension deadline; delisting determination issued Nov 19.
- Appeal filed Nov 27; hearing stayed pending Panel decision; hearing scheduled Jan 30, 2025.
- Materials due Jan 10, 2025; no assurance Panel will grant more time to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224048431/0001493152-24-048431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315224048431/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-048431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer